Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.

scientific article published on 8 March 2018

Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ACTBIO.2018.03.002
P698PubMed publication ID29526828

P2093author name stringSteven R Little
Ethan J Bassin
Michelle L Ratay
Stephen C Balmert
P577publication date2018-03-08
P1433published inActa BiomaterialiaQ4676719
P1476titleControlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.

Reverse relations

cites work (P2860)
Q92189867Association Between Dry Eye Disease and Migraine Headaches in a Large Population-Based Study
Q61800264Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease
Q59125138The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy
Q64277594The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model

Search more.